|
|
ARNA Discussion Board
|
|
||
Ozanimod metabolites Celgene seems to have satisfied FDA on the metabolites issue for their MS filing as the NDA has now been accepted for review. Is it likely there will be issues with metabolites for their P3 studies for Crohn's and/or UC or will the work on metabolites for MS be adequate for the other indications? |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
42492 | Re: Ozanimod metabolites | mrmarkaallen | 13 | 7/17/2019 6:13:44 PM |
42511 | Re: Ozanimod metabolites | daxtrdr | 6 | 7/18/2019 6:26:36 PM |